Met Life Investment Management, LLC Artivion, Inc. Transaction History

Met Life Investment Management, LLC

  • $18 Billion
  • Q4 2024

A detailed history of Met Life Investment Management, LLC transactions in Artivion, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 24,103 shares of AORT stock, worth $594,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,103
Previous 22,432 7.45%
Holding current value
$594,621
Previous $597,000 16.08%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$25.41 - $30.11 $42,460 - $50,313
1,671 Added 7.45%
24,103 $693,000
Q2 2024

Aug 13, 2024
BUY
$19.62 - $25.65 $42,320 - $55,327
2,157 Added 10.64%
22,432 $575,000
Q1 2024

May 14, 2024
BUY
$16.7 - $21.63 $338,592 - $438,548
20,275 New
20,275 $429,000
Q2 2023

Apr 29, 2024
BUY
$12.78 - $17.23 $259,114 - $349,338
20,275 New
20,275 $348,000
Q1 2023

May 09, 2024
BUY
$11.74 - $14.12 $238,028 - $286,283
20,275 New
20,275 $266 Million
Q1 2022

May 10, 2024
BUY
$16.95 - $21.74 $343,661 - $440,778
20,275 New
20,275 $433,000
Q1 2022

Mar 22, 2023
BUY
$16.95 - $21.74 $127,887 - $164,028
7,545 Added 59.27%
20,275 $433,000
Q1 2022

May 12, 2022
BUY
$16.95 - $21.74 $127,887 - $164,028
7,545 Added 59.27%
20,275 $433,000
Q4 2021

Jun 21, 2023
SELL
$17.19 - $22.84 $129,698 - $172,327
-7,545 Reduced 37.21%
12,730 $259,000
Q3 2021

Jun 21, 2023
SELL
$22.29 - $28.7 $168,178 - $216,541
-7,545 Reduced 37.21%
12,730 $283,000
Q2 2021

Jun 21, 2023
SELL
$22.32 - $32.07 $168,404 - $241,968
-7,545 Reduced 37.21%
12,730 $361,000
Q1 2021

May 17, 2024
SELL
$22.07 - $26.31 $166,518 - $198,508
-7,545 Reduced 37.21%
12,730 $287,000
Q1 2021

Jun 26, 2023
SELL
$22.07 - $26.31 $166,518 - $198,508
-7,545 Reduced 37.21%
12,730 $287 Million
Q1 2021

Mar 22, 2023
SELL
$22.07 - $26.31 $99,094 - $118,131
-4,490 Reduced 26.07%
12,730 $287,000
Q1 2021

May 14, 2021
SELL
$22.07 - $26.31 $99,094 - $118,131
-4,490 Reduced 26.07%
12,730 $287,000
Q4 2020

Jun 22, 2023
SELL
$16.76 - $23.74 $51,201 - $72,525
-3,055 Reduced 15.07%
17,220 $406,000
Q3 2020

Jun 26, 2023
SELL
$16.35 - $21.4 $49,949 - $65,376
-3,055 Reduced 15.07%
17,220 $318,000
Q2 2020

May 24, 2024
SELL
$16.34 - $25.24 $49,918 - $77,108
-3,055 Reduced 15.07%
17,220 $330 Million
Q2 2020

Jun 26, 2023
SELL
$16.34 - $25.24 $49,918 - $77,108
-3,055 Reduced 15.07%
17,220 $330,000
Q1 2020

Jul 12, 2023
SELL
$14.66 - $30.57 $44,786 - $93,391
-3,055 Reduced 15.07%
17,220 $291,000
Q4 2019

Jul 12, 2023
SELL
$22.45 - $27.09 $68,584 - $82,759
-3,055 Reduced 15.07%
17,220 $466,000
Q3 2019

Jul 12, 2023
SELL
$25.98 - $30.8 $79,368 - $94,094
-3,055 Reduced 15.07%
17,220 $467,000
Q2 2019

Jul 12, 2023
SELL
$27.55 - $32.39 $84,165 - $98,951
-3,055 Reduced 15.07%
17,220 $515,000
Q1 2019

Jul 13, 2023
SELL
$25.85 - $30.47 $78,971 - $93,085
-3,055 Reduced 15.07%
17,220 $502,000
Q4 2018

Jul 13, 2023
SELL
$25.76 - $34.03 $78,696 - $103,961
-3,055 Reduced 15.07%
17,220 $488,000
Q4 2018

Mar 22, 2023
SELL
$25.76 - $34.03 $217,491 - $287,315
-8,443 Reduced 32.9%
17,220 $488,000
Q4 2018

Feb 14, 2019
SELL
$25.76 - $34.03 $217,491 - $287,315
-8,443 Reduced 32.9%
17,220 $489,000
Q3 2018

Jul 13, 2023
SELL
$28.6 - $35.75 $87,373 - $109,216
-3,055 Reduced 15.07%
17,220 $606,000
Q3 2018

Mar 22, 2023
BUY
$28.6 - $35.75 $154,096 - $192,621
5,388 Added 26.57%
25,663 $903,000
Q3 2018

Nov 14, 2018
BUY
$28.6 - $35.75 $241,469 - $301,837
8,443 Added 49.03%
25,663 $903,000
Q4 2017

Feb 15, 2018
BUY
$18.65 - $23.85 $321,153 - $410,697
17,220
17,220 $330,000

Others Institutions Holding AORT

# of Institutions
175
Shares Held
35.5M
Call Options Held
29.9K
Put Options Held
2.3K
View Full List

About ARTIVION, INC.

AORT Quotes by TradingView
  • Ticker AORT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 40,316,100
  • Market Cap $995M
  • Description
  • Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...
More about AORT
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email